Neogen Stock Performance

NEOG Stock  USD 12.33  0.19  1.57%   
The company secures a Beta (Market Risk) of 0.28, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Neogen is expected to be smaller as well. At this point, Neogen has a negative expected return of -0.31%. Please make sure to verify Neogen's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Neogen performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neogen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Actual Historical Performance (%)

One Day Return
(1.65)
Five Day Return
(3.01)
Ten Year Return
(34.29)
All Time Return
2.6 K
Last Split Factor
2:1
Last Split Date
2021-06-07
1
Acquisition by Boehm William T of 18653 shares of Neogen at 13.58 subject to Rule 16b-3
10/24/2024
2
Disposition of 38760 shares by John Adent of Neogen at 13.81 subject to Rule 16b-3
10/28/2024
3
Acquisition by Woteki Catherine E of 1776 shares of Neogen at 13.81 subject to Rule 16b-3
10/29/2024
4
Insider Trading
11/01/2024
5
Neogen Corp Trading Down 3.2 percent on Nov 12
11/12/2024
6
Why Neogen Chemicals Shaky Earnings Are Just The Beginning Of Its Problems
11/20/2024
7
Neogen to Participate in the 36th Annual Piper Sandler Healthcare Conference
11/27/2024
8
Neogen Co. Holdings Raised by Fred Alger Management LLC
11/29/2024
9
Neogen Corp Shares Gap Down to 13.205 on Dec 3
12/03/2024
10
Janus Henderson Group PLC Buys 1,843 Shares of Neogen Co.
12/06/2024
11
Veterinary Eye Care Market to Grow by USD 1.05 Billion , Report on AI-Powered Market Evolution and Rising Pet Ownership - Technavio
12/13/2024
12
Neogen Launches Petrifilm Bacillus cereus Count Plate to Enhance Food Safety Testing Efficiency
12/17/2024
13
Food Processing Distributor Nelson-Jameson Announces New Distribution Center in Fairview, Pennsylvania
12/20/2024
14
Heres Why Neogen Chemicals Has A Meaningful Debt Burden
12/26/2024
Begin Period Cash Flow163.2 M
  

Neogen Relative Risk vs. Return Landscape

If you would invest  1,489  in Neogen on October 5, 2024 and sell it today you would lose (290.00) from holding Neogen or give up 19.48% of portfolio value over 90 days. Neogen is currently does not generate positive expected returns and assumes 2.8084% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Neogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Neogen is expected to under-perform the market. In addition to that, the company is 3.45 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.02 per unit of volatility.

Neogen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Neogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neogen, and traders can use it to determine the average amount a Neogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1102

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNEOG

Estimated Market Risk

 2.81
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.31
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Neogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neogen by adding Neogen to a well-diversified portfolio.

Neogen Fundamentals Growth

Neogen Stock prices reflect investors' perceptions of the future prospects and financial health of Neogen, and Neogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neogen Stock performance.

About Neogen Performance

By analyzing Neogen's fundamental ratios, stakeholders can gain valuable insights into Neogen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neogen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neogen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 172.59  201.93 
Return On Tangible Assets(0.01)(0.01)
Return On Capital Employed 0.01  0.01 

Things to note about Neogen performance evaluation

Checking the ongoing alerts about Neogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Neogen generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 924.22 M. Net Loss for the year was (9.42 M) with profit before overhead, payroll, taxes, and interest of 409.2 M.
Neogen has a poor financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: Heres Why Neogen Chemicals Has A Meaningful Debt Burden
Evaluating Neogen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Neogen's stock performance include:
  • Analyzing Neogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neogen's stock is overvalued or undervalued compared to its peers.
  • Examining Neogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Neogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neogen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Neogen's stock. These opinions can provide insight into Neogen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Neogen's stock performance is not an exact science, and many factors can impact Neogen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Neogen Stock analysis

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world